Essity sets October 22 date for Q3FY26 interim report release

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Essity will publish Q3FY26 interim report on October 22, 2026 at 7:00 am CET
  • CEO Ulrika Kolsrud and CFO Fredrik Rystedt to present results at 9:00 am CET webcast
  • Conference call access available for UK, USA, and Sweden participants
powered bylight_fuzz_icon
51603913

*this image is generated using AI for illustrative purposes only.

Essity will publish its interim report for the third quarter of fiscal year 2026 on October 22. The hygiene and health company scheduled the release for approximately 7:00 am CET.

President and CEO Ulrika Kolsrud, alongside EVP and CFO Fredrik Rystedt, will present the financial results. Management will host a live webcast and teleconference at 9:00 am CET on the same day to discuss the performance.

Investors can access the presentation via the official webcast link. The session will remain available for on-demand viewing after the live broadcast concludes.

Conference details

Participants wishing to join the question-and-answer session must dial in advance. The company provided specific dial-in numbers for various regions:

  • UK: +44 (0) 33 0551 02 00
  • USA: +1 786 697 35 01
  • Sweden: +46 (0)8 505 204 24

Callers should indicate "Essity" when connecting to the conference line.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What strategic priorities will management emphasize during the Q3 presentation?

How are current market conditions expected to impact Essity's financial performance in the coming quarters?

Will the company provide updated guidance for the remainder of fiscal year 2026?

like20
dislike

Essity acquires Kenvue's Brazil feminine care business for $284M

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

Essity acquires Kenvue's Brazilian feminine care assets, including Carefree and Sempre Livre, for $284 million. The target generated BRL 800m in trailing net sales. The deal closes in Q2 2027 pending regulatory approvals.

powered bylight_fuzz_icon
48705215

*this image is generated using AI for illustrative purposes only.

Essity has agreed to acquire Kenvue's feminine care business in Brazil for $284 million (approximately SEK 2.7 billion) on a cash and debt-free basis. The acquisition includes the market-leading brands Carefree, Sempre Livre, and o.b., along with related manufacturing equipment.

The deal strengthens Essity's position as a market leader in feminine care in Latin America. For the twelve-month period ending June 30, 2026, the acquired business generated net sales of approximately BRL 800 million (approximately SEK 1.4 billion) with good profitability.

Deal Details

Metric: Value:
Acquirer: Essity
Target Business: Kenvue's feminine care operations in Brazil
Deal Value: $284 million (SEK 2.7 billion)
Brands Included: Carefree, Sempre Livre, o.b.
Trailing Net Sales: BRL 800 million (SEK 1.4 billion)
Expected Closing: Second quarter of 2027

The transaction is structured as an asset purchase from certain Kenvue subsidiaries. It is subject to regulatory approval in Brazil, other customary closing conditions, and the completion of the Kimberly-Clark and Kenvue transaction.

Strategic Context

Ulrika Kolsrud, President and CEO of Essity, stated that the acquisition establishes a strong position in feminine care in Brazil and marks another step in the company's strategy to grow in its most value-creating categories. Brazil represents a significant growth opportunity in hygiene and health, where Essity already holds a leading position in incontinence products with its TENA brand.

Essity is a global player in feminine care, offering sanitary pads, liners, tampons, intimate soaps, intimate wipes, and leakproof apparel under brands such as Libresse, Bodyform, Nana, Saba, Libra, and Nosotras. In February 2026, Essity completed the acquisition of the Carefree, Stayfree, and o.b. brands in North America from Edgewell Personal Care.

Brazil is one of the world's largest hygiene markets and the fourth-largest feminine care market. Essity currently operates a production facility in Jarinu for its TENA brand and has an established presence in Professional Hygiene and Medical Solutions categories in the country.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might the integration of Carefree and Sempre Livre impact Essity's pricing power and market share against local competitors in Brazil's feminine care segment?

What specific operational synergies does Essity anticipate realizing from combining its new Brazilian assets with its existing TENA production facility in Jarinu?

Given the dependency on the Kimberly-Clark and Kenvue transaction, what are the potential risks or delays that could affect the expected Q2 2027 closing date?

like15
dislike